www.easilymeds2.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Zanamivir - Relenza
Generic Relenza
Generic Relenza is used to treat flu symptoms caused by influenza virus in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms. It will not treat the common cold.
$149.98
Buy now!
Choose Your language:
- Testimonials
-
thank you, i recieved my pills within one week of ordering them, cheers for the extra 4 you threw in as a bonus, and yes they worked great, cheers again.....
Read more »
-
- Liquidia touts promise of next-gen respiratory delivery - FierceDrugDelivery
- Liquidia touts promise of next-gen respiratory deliveryFierceDrugDeliveryIn one study, researchers took the API zanamivir and crafted a molecule with PRINT
- Study: H1N1 resistance to oseltamivir may spread - CIDRAP
- Study: H1N1 resistance to oseltamivir may spreadCIDRAP
- Ready, set, trial: why pandemics catch us out and how to prepare for them - Discover Magazine (blog)
- Discover Magazine (blog)Ready, set, trial: why pandemics catch us out and how to prepare for themDiscover Magazine (blog)Tamiflu's relatives, zanamivir and peramivir, are similarly mysterious
- Theraclone Passes First Clinical Test with Flu-Fighting Antibody - Xconomy
- XconomyTheraclone Passes First Clinical Test with Flu-Fighting AntibodyXconomyWhile there are already a couple of antiviral pills on the market—Roche's oseltamivir phosphate (Tamiflu) or GlaxoSmithKline's zanamivir (Relenza)—scientists worry about mutant strains like H5N1 “bird flu” that could emerge and resist today's
- Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention ... - MarketWatch (press release)
- Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
